ConforMIS (CFMS) Reports Q2 Loss of $2.51
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to ConforMIS (CFMS) Reports Q2 Loss of $2.51
August 11, 2015 7:30 AM EDT
BEDFORD, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2015.
Recent Accomplishments & Highlights
Achieved total revenue of $19.2 million, including $3.5 million related to the settlement of patent litigation, up 72% year-over-year on a reported basis and up 81% year-over-year on a constant currency basis.
Achieved product revenue of $15.8 million, up 41% year-over-year...
More
August 11, 2015 7:30 AM EDT
BEDFORD, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the second quarter ended June 30, 2015.
Recent Accomplishments & Highlights
Achieved total revenue of $19.2 million, including $3.5 million related to the settlement of patent litigation, up 72% year-over-year on a reported basis and up 81% year-over-year on a constant currency basis.
Achieved product revenue of $15.8 million, up 41% year-over-year...
More
